Pediatric Cardiology

, Volume 39, Issue 6, pp 1090–1098 | Cite as

Fates Aligned: Origins and Mechanisms of Ventricular Conduction System and Ventricular Wall Development

  • William R. Goodyer
  • Sean M. Wu
Riley Symposium


The cardiac conduction system is a network of distinct cell types necessary for the coordinated contraction of the cardiac chambers. The distal portion, known as the ventricular conduction system, allows for the rapid transmission of impulses from the atrio-ventricular node to the ventricular myocardium and plays a central role in cardiac function as well as disease when perturbed. Notably, its patterning during embryogenesis is intimately linked to that of ventricular wall formation, including trabeculation and compaction. Here, we review our current understanding of the underlying mechanisms responsible for the development and maturation of these interdependent processes.


Conduction system Myocardial development Arrhythmia 



This work was supported by the NIH Office of Director’s Pioneer Award LM012179-03, the American Heart Association Established Investigator Award 17EIA33410923, the Department of Pediatrics and Division of Pediatric Cardiology at Lucille Packard Children’s Hospital, the Stanford Cardiovascular Institute, the Stanford Division of Cardiovascular Medicine, Department of Medicine, the Institute for Stem Cell Biology and Regenerative Medicine, and an endowed faculty scholar award from the Stanford Child Health Research Institute/Lucile Packard Foundation for Children (S.M.W). This was also supported by the Training Grant (T32) entitled Research Training in Myocardial Biology at Stanford (NIH 2 T32 HL094274) (W.R.G.).

Compliance with Ethical Standards

Conflict of interest

W.R.G. declares that he has no conflict of interest. S.M.W. declares that he has no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    Miquerol L, Moreno-Rascon N, Beyer S et al (2010) Biphasic development of the mammalian ventricular conduction system. Circ Res 107:153–161. CrossRefPubMedGoogle Scholar
  2. 2.
    Haissaguerre M, Vigmond E, Stuyvers B et al (2016) Ventricular arrhythmias and the His-Purkinje system. Nat Rev Cardiol 13:155–166. CrossRefPubMedGoogle Scholar
  3. 3.
    van Weerd JH, Christoffels VM (2016) The formation and function of the cardiac conduction system. Development 143:197–210. CrossRefPubMedGoogle Scholar
  4. 4.
    Steiner I (1988) History of Purkinje’s fibers. Cesk Fysiol 37:509–512PubMedGoogle Scholar
  5. 5.
    Davies F (1930) The conducting system of the bird’s heart. J Anat 64:129–146PubMedPubMedCentralGoogle Scholar
  6. 6.
    Sommer JR, Johnson EA (1968) Cardiac muscle. A comparative study of Purkinje fibers and ventricular fibers. J Cell Biol 36:497–526CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Samsa LA, Yang B, Liu J (2013) Embryonic cardiac chamber maturation: trabeculation, conduction, and cardiomyocyte proliferation. Am J Med Genet C 163C:157–168. CrossRefGoogle Scholar
  8. 8.
    Rentschler S, Vaidya DM, Tamaddon H et al (2001) Visualization and functional characterization of the developing murine cardiac conduction system. Development 128:1785–1792PubMedPubMedCentralGoogle Scholar
  9. 9.
    Sedmera D, Reckova M, DeAlmeida A et al (2003) Spatiotemporal pattern of commitment to slowed proliferation in the embryonic mouse heart indicates progressive differentiation of the cardiac conduction system. Anat Rec 274:773–777. CrossRefGoogle Scholar
  10. 10.
    Meysen S, Marger L, Hewett KW et al (2007) Nkx2.5 cell-autonomous gene function is required for the postnatal formation of the peripheral ventricular conduction system. Dev Biol 303:740–753. CrossRefPubMedGoogle Scholar
  11. 11.
    Kim K-H, Rosen A, Hussein SMI et al (2016) Irx3 is required for postnatal maturation of the mouse ventricular conduction system. Sci Rep 6:19197. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Sedmera D, Pexieder T, Vuillemin M et al (2000) Developmental patterning of the myocardium. Anat Rec 258:319–337CrossRefPubMedGoogle Scholar
  13. 13.
    Moorman AFM, Christoffels VM (2003) Cardiac chamber formation: development, genes, and evolution. Physiol Rev 83:1223–1267. CrossRefPubMedGoogle Scholar
  14. 14.
    Zhang W, Chen H, Qu X et al (2013) Molecular mechanism of ventricular trabeculation/compaction and the pathogenesis of the left ventricular noncompaction cardiomyopathy (LVNC). Am J Med Genet C 163C:144–156. CrossRefGoogle Scholar
  15. 15.
    Gorza L, Schiaffino S, Vitadello M (1988) Heart conduction system: a neural crest derivative? Brain Res 457:360–366CrossRefPubMedGoogle Scholar
  16. 16.
    Gourdie RG, Mima T, Thompson RP, Mikawa T (1995) Terminal diversification of the myocyte lineage generates Purkinje fibers of the cardiac conduction system. Development 121:1423–1431PubMedGoogle Scholar
  17. 17.
    Cheng G, Litchenberg WH, Cole GJ et al (1999) Development of the cardiac conduction system involves recruitment within a multipotent cardiomyogenic lineage. Development 126:5041–5049PubMedGoogle Scholar
  18. 18.
    Jiang X, Rowitch DH, Soriano P et al (2000) Fate of the mammalian cardiac neural crest. Development 127:1607–1616PubMedGoogle Scholar
  19. 19.
    Delorme B, Dahl E, Jarry-Guichard T et al (1995) Developmental regulation of connexin 40 gene expression in mouse heart correlates with the differentiation of the conduction system. Dev Dyn 204:358–371. CrossRefPubMedGoogle Scholar
  20. 20.
    Delorme B, Dahl E, Jarry-Guichard T et al (1997) Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system. Circ Res 81:423–437CrossRefPubMedGoogle Scholar
  21. 21.
    Erokhina IL, Rumyantsev PP (1988) Proliferation and biosynthetic activities of myocytes from conductive system and working myocardium of the developing mouse heart. Light microscopic autoradiographic study. Acta Histochem 84:51–66. CrossRefPubMedGoogle Scholar
  22. 22.
    Sedmera D, Thompson RP (2011) Myocyte proliferation in the developing heart. Dev Dyn 240:1322–1334. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Miquerol L, Bellon A, Moreno N et al (2013) Resolving cell lineage contributions to the ventricular conduction system with a Cx40-GFP allele: a dual contribution of the first and second heart fields. Dev Dyn 242:665–677. CrossRefPubMedGoogle Scholar
  24. 24.
    Später D, Abramczuk MK, Buac K et al (2013) A HCN4 + cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells. Nat Cell Biol 15:1098–1106. CrossRefPubMedGoogle Scholar
  25. 25.
    Liang X, Wang G, Lin L et al (2013) HCN4 dynamically marks the first heart field and conduction system precursors. Circ Res 113:399–407. CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Tsai S-Y, Maass K, Lu J et al (2015) Efficient generation of cardiac Purkinje cells from ESCs by activating cAMP signaling. Stem Cell Rep 4:1089–1102. CrossRefGoogle Scholar
  27. 27.
    Maass K, Shekhar A, Lu J et al (2015) Isolation and characterization of embryonic stem cell-derived cardiac Purkinje cells. Stem Cells 33:1102–1112. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Li G, Xu A, Sim S et al (2016) Transcriptomic profiling maps anatomically patterned subpopulations among single embryonic cardiac cells. Dev Cell 39:491–507. CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Paige SL, Plonowska K, Xu A, Wu SM (2015) Molecular regulation of cardiomyocyte differentiation. Circ Res 116:341–353. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Munshi NV (2012) Gene regulatory networks in cardiac conduction system development. Circ Res 110:1525–1537. CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    de la Pompa JL, Epstein JA (2012) Coordinating tissue interactions: notch signaling in cardiac development and disease. Dev Cell 22:244–254. CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Christoffels VM, Smits GJ, Kispert A, Moorman AFM (2010) Development of the pacemaker tissues of the heart. Circ Res 106:240–254. CrossRefPubMedGoogle Scholar
  33. 33.
    Hatcher CJ, Basson CT (2009) Specification of the cardiac conduction system by transcription factors. Circ Res 105:620–630. CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Grego-Bessa J, Luna-Zurita L, del Monte G et al (2007) Notch signaling is essential for ventricular chamber development. Dev Cell 12:415–429. CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Rentschler S, Morley GE, Fishman GI (2002) Molecular and functional maturation of the murine cardiac conduction system. In: Cold Spring Harbor symposia on quantitative biology, vol 67. Cold Spring Harbor Laboratory Press, New York, pp 353–361Google Scholar
  36. 36.
    Hertig CM, Kubalak SW, Wang Y, Chien KR (1999) Synergistic roles of neuregulin-1 and insulin-like growth factor-I in activation of the phosphatidylinositol 3-kinase pathway and cardiac chamber morphogenesis. J Biol Chem 274:37362–37369CrossRefPubMedGoogle Scholar
  37. 37.
    Gourdie RG, Wei Y, Kim D et al (1998) Endothelin-induced conversion of embryonic heart muscle cells into impulse-conducting Purkinje fibers. Proc Natl Acad Sci USA 95:6815–6818CrossRefPubMedGoogle Scholar
  38. 38.
    Chen H, Zhang W, Sun X et al (2013) Fkbp1a controls ventricular myocardium trabeculation and compaction by regulating endocardial Notch1 activity. Development 140:1946–1957. CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Rentschler S, Yen AH, Lu J et al (2012) Myocardial Notch signaling reprograms cardiomyocytes to a conduction-like phenotype. Circulation 126:1058–1066. CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Khandekar A, Springer S, Wang W et al (2016) Notch-mediated epigenetic regulation of voltage-gated potassium currents. Circ Res 119:1324–1338. CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Moskowitz IPG, Kim JB, Moore ML et al (2007) A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129:1365–1376. CrossRefPubMedGoogle Scholar
  42. 42.
    Jongbloed MRM, Vicente-Steijn R, Douglas YL et al (2011) Expression of Id2 in the second heart field and cardiac defects in Id2 knock-out mice. Dev Dyn 240:2561–2577. CrossRefPubMedGoogle Scholar
  43. 43.
    Zhang S-S, Kim K-H, Rosen A et al (2011) Iroquois homeobox gene 3 establishes fast conduction in the cardiac His-Purkinje network. Proc Natl Acad Sci USA 108:13576–13581. CrossRefPubMedGoogle Scholar
  44. 44.
    Koizumi A, Sasano T, Kimura W et al (2016) Genetic defects in a His-Purkinje system transcription factor, IRX3, cause lethal cardiac arrhythmias. Eur Heart J 37:1469–1475. CrossRefPubMedGoogle Scholar
  45. 45.
    Thomas PS, Kasahara H, Edmonson AM et al (2001) Elevated expression of Nkx-2.5 in developing myocardial conduction cells. Anat Rec 263:307–313CrossRefPubMedGoogle Scholar
  46. 46.
    Pashmforoush M, Lu JT, Chen H et al (2004) Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117:373–386CrossRefPubMedGoogle Scholar
  47. 47.
    Tanaka M, Berul CI, Ishii M et al (2002) A mouse model of congenital heart disease: cardiac arrhythmias and atrial septal defect caused by haploinsufficiency of the cardiac transcription factor Csx/Nkx2.5. In: Cold Spring Harbor symposia on quantitative biology, vol 67, pp 317–325Google Scholar
  48. 48.
    Jay PY, Harris BS, Maguire CT et al (2004) Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest 113:1130–1137. CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Schott JJ, Benson DW, Basson CT et al (1998) Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281:108–111CrossRefPubMedGoogle Scholar
  50. 50.
    Chen H, Shi S, Acosta L et al (2004) BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development 131:2219–2231. CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Shin CH, Liu Z-P, Passier R et al (2002) Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110:725–735CrossRefPubMedGoogle Scholar
  52. 52.
    Ismat FA, Zhang M, Kook H et al (2005) Homeobox protein Hop functions in the adult cardiac conduction system. Circ Res 96:898–903. CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Benjamin EJ, Blaha MJ, Chiuve SE et al (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:e146–e603. CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    John RM, Tedrow UB, Koplan BA et al (2012) Ventricular arrhythmias and sudden cardiac death. Lancet 380:1520–1529. CrossRefPubMedGoogle Scholar
  55. 55.
    Scheinman MM (2009) Role of the His-Purkinje system in the genesis of cardiac arrhythmia. Heart Rhythm 6:1050–1058. CrossRefPubMedGoogle Scholar
  56. 56.
    Kim EE, Shekhar A, Lu J et al (2014) PCP4 regulates Purkinje cell excitability and cardiac rhythmicity. J Clin Invest 124:5027–5036. CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Herron TJ, Milstein ML, Anumonwo J et al (2010) Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 7:1122–1128. CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Morley GE, Danik SB, Bernstein S et al (2005) Reduced intercellular coupling leads to paradoxical propagation across the Purkinje-ventricular junction and aberrant myocardial activation. Proc Natl Acad Sci USA 102:4126–4129. CrossRefPubMedGoogle Scholar
  59. 59.
    Behradfar E, Nygren A, Vigmond EJ (2014) The role of Purkinje-myocardial coupling during ventricular arrhythmia: a modeling study. PLoS ONE 9:e88000. CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Gude NA, Emmanuel G, Wu W et al (2008) Activation of Notch-mediated protective signaling in the myocardium. Circ Res 102:1025–1035. CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Bezzina CR, Barc J, Mizusawa Y et al (2013) Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet 45:1044–1049. CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Benson DW, Silberbach GM, Kavanaugh-McHugh A et al (1999) Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 104:1567–1573. CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Xie H, Chen X, Chen N, Zhou Q (2017) Sudden death in a male infant due to histiocytoid cardiomyopathy: an autopsy case and review of the literature. Am J Forensic Med Pathol 38:32–34. CrossRefPubMedGoogle Scholar
  64. 64.
    Finsterer J (2008) Histiocytoid cardiomyopathy: a mitochondrial disorder. Clin Cardiol 31:225–227. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Cardiovascular InstituteStanford UniversityStanfordUSA
  2. 2.Division of Pediatric Cardiology, Department of PediatricsLucille Packard Children’s HospitalPalo AltoUSA
  3. 3.Institute for Stem Cell Biology and Regenerative MedicineStanfordUSA
  4. 4.Division of Cardiovascular Medicine, Department of MedicineStanford University School of MedicineStanfordUSA

Personalised recommendations